FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Rosenfeld

Research Profile

Disorders

Chemicals & Drugs

Physiology

Visual Acuity

Procedures

Anatomy

Vitreous Body

Concepts & Ideas

Co-author Network

Publications

TOP 3
Gary Shienbaum; William E Smiddy; Harry W Flynn; Carlos Alexandre de Amorim Garcia Filho; Renata Portella Nunes; Philip J Rosenfeld
Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy.
Zohar Yehoshua; Paul F Stetson; William J Feuer; Carlos Alexandre A Garcia Filho; Giovanni Gregori; Fernando M Penha; Philip J Rosenfeld
Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image.
Fernando M Penha; William J Feuer; Carlos Alexandre de Amorim Garcia Filho; Giovanni Gregori; Zohar Yehoshua; Philip J Rosenfeld
Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Rosenfeld (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gary Shienbaum; William E Smiddy; Harry W Flynn; Carlos Alexandre de Amorim Garcia Filho; Renata Portella Nunes; Philip J Rosenfeld
Management of submacular hemorrhage secondary to neovascular age-related macular degeneration with anti-vascular endothelial growth factor monotherapy.
American journal of ophthalmology 2013;155(6):1009-13.
2013: Zohar Yehoshua; Paul F Stetson; William J Feuer; Carlos Alexandre A Garcia Filho; Giovanni Gregori; Fernando M Penha; Philip J Rosenfeld
Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image.
Ophthalmic surgery, lasers & imaging retina 2013;44(2):127-32.
2013: Fernando M Penha; William J Feuer; Carlos Alexandre de Amorim Garcia Filho; Giovanni Gregori; Zohar Yehoshua; Philip J Rosenfeld
Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy.
Retina (Philadelphia, Pa.) 2013;33(3):459-66.
2013: Zohar Yehoshua; Srinivas R Sadda; William J Feuer; Raquel Goldhardt; Giovanni Gregori; Pooja Gupta; Ranjith K Konduru; Ying Li; Muneeswar G Nittala; Fernando M Penha; Philip J Rosenfeld
Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging.
Investigative ophthalmology & visual science 2013;54(4):2429-34.
2013: Fernando M Penha; William J Feuer; Giovanni Gregori; Zohar Yehoshua; Philip J Rosenfeld
Identifying the boundaries of retinal pigment epithelial detachments using two spectral-domain optical coherence tomography instruments.
Ophthalmic surgery, lasers & imaging retina 2013;44(1):10-6.
2013: William J Feuer; Giovanni Gregori; Anne S Lindblad; Fernando M Penha; Emily Y Chew; Traci E Clemons; Frederick L Ferris; Zohar Yehoshua; Philip J Rosenfeld
Square root transformation of geographic atrophy area measurements to eliminate dependence of growth rates on baseline lesion measurements: a reanalysis of age-related eye disease study report no. 26.
JAMA ophthalmology 2013;131(1):110-1.
2012: Andrew P Schachat; Thomas J Liesegang; Philip J Rosenfeld; Michael W Stewart
Endophthalmitis is not a "never event".
Ophthalmology 2012;119(8):1507-8.
2012: David J Browning; Peter K Kaiser; Philip J Rosenfeld; Michael W Stewart
Aflibercept for age-related macular degeneration: a game-changer or quiet addition?
American journal of ophthalmology 2012;154(2):222-6.
2012: Michael W Stewart; Fenghua Wang; Zohar Yehoshua; Elena Bueno-Lopez; Fernando M Penha; Philip J Rosenfeld; Pedro F Lopez
Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor Trap-eye).
Retina (Philadelphia, Pa.) 2012;32(3):434-57.
2012: Fernando M Penha; Philip J Rosenfeld; Fenghua Wang; Zohar Yehoshua; Manuel Falcão; Giovanni Gregori; William J Feuer
Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography.
American journal of ophthalmology 2012;153(3):515-23.
2012: Philip J Rosenfeld
Scientific giant.
Retina (Philadelphia, Pa.) 2012;32 Suppl 1():S20-1.
2012: Serafin Gonzalez; Philip J Rosenfeld; Michael W Stewart; Jennifer Brown; Steven P Murphy
Avastin doesn't blind people, people blind people.
American journal of ophthalmology 2012;153(2):196-203.e1.
2012: Zohar Yehoshua; Philip J Rosenfeld
Strategies for following dry age-related macular degeneration.
Ophthalmic research 2012;48 Suppl 1():6-10.
2012: James Banta; Philip J Rosenfeld
Cataract surgery and intraocular lens selection in patients with age-related macular degeneration: pearls for success.
International ophthalmology clinics 2012;52(2):73-80.
2011: Ying Li; Giovanni Gregori; Byron Lam; Philip J Rosenfeld
Automatic montage of SD-OCT data sets.
Optics express 2011;19(27):26239-48.
2011: Zohar Yehoshua; William J Feuer; Fernando M Penha; Philip J Rosenfeld; Fenghua Wang; Giovanni Gregori
Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography.
Ophthalmology 2011;118(12):2434-41.
2011: Charles C Wykoff; Harry W Flynn; Philip J Rosenfeld
Prophylaxis for endophthalmitis following intravitreal injection: antisepsis and antibiotics.
American journal of ophthalmology 2011;152(5):717-9.e2.
2011: Philip J Rosenfeld; Howard Shapiro; Pamela Wong; Jason S Ehrlich
Cataract surgery in ranibizumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials.
American journal of ophthalmology 2011;152(5):793-8.
2011: Giovanni Gregori; Ninel Z Gregori; Brandon J Lujan; Carmen A Puliafito; Philip J Rosenfeld; Fenghua Wang; Zohar Yehoshua; William J Feuer
Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration.
Ophthalmology 2011;118(7):1373-9.
2011: Philip J Rosenfeld
Bevacizumab versus ranibizumab for AMD.
The New England journal of medicine 2011;364(20):1966-7.
2011: Zohar Yehoshua; Philip J Rosenfeld; Thomas Albini
Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures.
Seminars in ophthalmology 2011;26(3):167-80.
2011: Ross J Brechner; Philip J Rosenfeld; J Daniel Babish; Stuart Caplan
Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file.
American journal of ophthalmology 2011;151(5):887-895.e1.
2011: Andrew A Moshfeghi; Timothy G Murray; Philip J Rosenfeld; Stephen Schwartz; William E Smiddy; Thomas Albini; Audina M Berrocal; Janet L Davis; Sander Dubovy; Harry W Flynn; Jaclyn Kovach; Geeta Lalchandani-Lalwani; Wen-Hsiang Lee; Carmen A Puliafito
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Retina (Philadelphia, Pa.) 2011;31(4):662-8.
2011: Zohar Yehoshua; Philip J Rosenfeld; Giovanni Gregori; William J Feuer; Manuel Falcão; Brandon J Lujan; Carmen Puliafito
Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography.
Ophthalmology 2011;118(4):679-86.
2011: Philip J Rosenfeld; Howard Shapiro; Lisa Tuomi; Mary Webster; Julee Elledge; Barbara Blodi
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials.
Ophthalmology 2011;118(3):523-30.
2011: Ying Li; Giovanni Gregori; Robert W Knighton; Brandon J Lujan; Philip J Rosenfeld
Registration of OCT fundus images with color fundus photographs based on blood vessel ridges.
Optics express 2011;19(1):7-16.
2010: Zohar Yehoshua; Philip J Rosenfeld; Giovanni Gregori; Fernando Penha
Spectral domain optical coherence tomography imaging of dry age-related macular degeneration.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2010;41 Suppl():S6-S14.
2010: Marco A Zarbin; Philip J Rosenfeld
Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives.
Retina (Philadelphia, Pa.) 2010;30(9):1350-67.
2010: Ninel Z Gregori; William Feuer; Philip J Rosenfeld
Novel method for analyzing snellen visual acuity measurements.
Retina (Philadelphia, Pa.) 2010;30(7):1046-50.
2010: Usha Chakravarthy; Jennifer Evans; Philip J Rosenfeld
Age related macular degeneration.
BMJ (Clinical research ed.) 2010;340():c981.
2009: Giuseppe Querques; Nicola Delle Noci; Thomas Aaberg; Philip J Rosenfeld
Diagnostic and therapeutic challenges.
Retina (Philadelphia, Pa.) 2009;29(8):1195-200.
2009: Kimberly E Stepien; Philip J Rosenfeld; Carmen A Puliafito; William Feuer; Wei Shi; Luma Al-Attar; Sander Dubovy; Timothy G Murray; Janet L Davis; Wen-Hsiang Lee; Stephen Schwartz; William E Smiddy; Audina M Berrocal; Harry W Flynn
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) 2009;29(8):1067-73.
2009: Theodore Leng; Philip J Rosenfeld; Giovanni Gregori; Carmen A Puliafito; Omar S Punjabi
Spectral domain optical coherence tomography characteristics of cuticular drusen.
Retina (Philadelphia, Pa.) 2009;29(7):988-93.
2009: Ninel Z Gregori; Ginger Henson Rattan; Philip J Rosenfeld; Carmen A Puliafito; William Feuer; Harry W Flynn; Audina M Berrocal; Luma Al-Attar; Sander Dubovy; William E Smiddy; Stephen Schwartz; Wen-Hsiang Lee; Timothy G Murray
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion.
Retina (Philadelphia, Pa.) 2009;29(7):913-25.
2009: Geeta Lalchandani-Lalwani; Philip J Rosenfeld; Anne E Fung; Sander Dubovy; Stephan Michels; William Feuer; Janet L Davis; Harry W Flynn; Maria Esquiabro
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
American journal of ophthalmology 2009;148(1):43-58.e1.
2009: Thomas A Ciulla; Philip J Rosenfeld
Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Current opinion in ophthalmology 2009;20(3):158-65.
2009: Thomas A Ciulla; Philip J Rosenfeld
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Current opinion in ophthalmology 2009;20(3):166-74.
2009: Philip J Rosenfeld; Kenneth Goodman
When is off-label drug use in the patient's best interest?
American journal of ophthalmology 2009;147(5):761-3.
2009: A L Moraczewski; Richard Lee; Paul F Palmberg; Philip J Rosenfeld; William J Feuer
Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
The British journal of ophthalmology 2009;93(5):589-93.
2009: Brandon J Lujan; Philip J Rosenfeld; Giovanni Gregori; Fenghua Wang; Robert W Knighton; William J Feuer; Carmen A Puliafito
Spectral domain optical coherence tomographic imaging of geographic atrophy.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2009;40(2):96-101.
2009: Ninel Z Gregori; Audina M Berrocal; Giovanni Gregori; Timothy G Murray; R W Knighton; Harry W Flynn; Sander Dubovy; C A Puliafito; Philip J Rosenfeld
Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis.
The British journal of ophthalmology 2009;93(3):373-8.
2009: Jaclyn Kovach; Philip J Rosenfeld
Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
Retina (Philadelphia, Pa.) 2009;29(1):27-32.
2009: Izabela Komarowska; Gad Heilweil; Philip J Rosenfeld; Ido Perlman; Anat Loewenstein
Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
Retina (Philadelphia, Pa.) 2009;29(1):98-105.
2008: Wolfgang Geitzenauer; Stephan Michels; Franz Prager; Philip J Rosenfeld; Gabriela Kornek; Laurenz Vormittag; Ursula Schmidt-Erfurth
Comparison of 2.5 mg/kg and 5 mg/kg systemic bevacizumab in neovascular age-related macular degeneration: twenty-four week results of an uncontrolled, prospective cohort study.
Retina (Philadelphia, Pa.) 2008;28(10):1375-86.
2008: Ninel Z Gregori; Jaime Gaitan; Philip J Rosenfeld; Carmen A Puliafito; William Feuer; Harry W Flynn; Audina M Berrocal; Luma Al-Attar; Sander Dubovy; William E Smiddy; Stephen Schwartz; Wen-Hsiang Lee; Timothy G Murray
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2008;28(9):1325-37.
2008: Omar S Punjabi; Ryan Rich; Janet L Davis; Giovanni Gregori; Harry W Flynn; Brandon J Lujan; Philip J Rosenfeld; Carmen A Puliafito
Imaging serpiginous choroidopathy with spectral domain optical coherence tomography.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008;39(4 Suppl):S95-8.
2008: Brandon J Lujan; Fenghua Wang; Giovanni Gregori; Philip J Rosenfeld; Robert W Knighton; Carmen A Puliafito; Ronald P Danis; Larry D Hubbard; Robert Chang; Donald L Budenz; Michael I Seider; O'Rese Knight
Calibration of fundus images using spectral domain optical coherence tomography.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008;39(4 Suppl):S15-20.
2008: M W Stewart; Philip J Rosenfeld
Predicted biological activity of intravitreal VEGF Trap.
The British journal of ophthalmology 2008;92(5):667-8.
2008: Xiao-Dong Sun; Wei-Qi Xu; Philip J Rosenfeld
[Therapeutic efficacy and safety of off-label use of Bevacizumab for the treatment of neovascular diseases of the eye].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2008;44(3):281-4.
2008: Gabriel Tsechpenakis; Brandon Lujan; Oscar Martinez; Giovanni Gregori; Philip J Rosenfeld
Geometric deformable model driven by CoCRFs: application to optical coherence tomography.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2008;11(Pt 1):883-91.
2007: Philip J Rosenfeld; David S Boyer; Neil M Bressler; Gary Fish; W Sanderson Grizzard; Yong Hao; Peter Hnik; Henry L Hudson; Lawrence J Singerman; Jason S Slakter
Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: one-year results of the VALIO Study.
American journal of ophthalmology 2007;144(6):970-972.
2007: Philip J Rosenfeld
New treatments for age-related macular degeneration.
Lancet 2007;370(9597):1479; author reply 1480.
2007: Steve Charles; Philip J Rosenfeld; Steven Gayer
Medical consequences of stopping anticoagulant therapy before intraocular surgery or intravitreal injections.
Retina (Philadelphia, Pa.) 2007;27(7):813-5.
2007: Anne E Fung; Geeta Lalchandani-Lalwani; Philip J Rosenfeld; Sander Dubovy; Stephan Michels; William J Feuer; Carmen A Puliafito; Janet L Davis; Harry W Flynn; Maria Esquiabro
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
American journal of ophthalmology 2007;143(4):566-83.
2007: Philip J Rosenfeld
Intravitreal Avastin for choroidal neovascularisation in pathological myopia: the controversy continues.
The British journal of ophthalmology 2007;91(2):128-30.
2007: Richard C Lin; Philip J Rosenfeld
Antiangiogenic therapy in neovascular age-related macular degeneration.
International ophthalmology clinics 2007;47(1):117-37.
2006: David A Saperstein; Philip J Rosenfeld; Neil M Bressler; Robert H Rosa; Paul Sternberg; Thomas M Aaberg; Thomas M Aaberg; Annemarie Weisberger
Verteporfin therapy for CNV secondary to OHS.
Ophthalmology 2006;113(12):2371.e1-3.
2006: Andrew A Moshfeghi; Philip J Rosenfeld; Carmen A Puliafito; Stephan Michels; Erin Marcus; Joshua Lenchus; Anna Venkatraman
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.
Ophthalmology 2006;113(11):2002.e1-12.
2006: Anne E Fung; Philip J Rosenfeld; E Reichel
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.
The British journal of ophthalmology 2006;90(11):1344-9.
2006: Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Ranibizumab for neovascular age-related macular degeneration.
The New England journal of medicine 2006;355(14):1419-31.
2006: Wolfgang Geitzenauer; Stephan Michels; Franz Prager; Gabriela V Kornek; Laurenz Vormittag; Philip J Rosenfeld; Ursula Schmidt-Erfurth
[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration].
Klinische Monatsblätter für Augenheilkunde 2006;223(10):822-7.
2006: Ninel Z Gregori; Philip J Rosenfeld; Carmen A Puliafito; Harry W Flynn; Ji Eun Lee; Elias C Mavrofrides; William E Smiddy; Timothy G Murray; Audina M Berrocal; Ingrid U Scott; Giovanni Gregori
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Retina (Philadelphia, Pa.) 2006;26(8):889-95.
2006: Philip J Rosenfeld; Ryan M Rich; Geeta Lalchandani-Lalwani
Ranibizumab: Phase III clinical trial results.
Ophthalmology clinics of North America 2006;19(3):361-72.
2006: Philip J Rosenfeld
Intravitreal avastin: the low cost alternative to lucentis?
American journal of ophthalmology 2006;142(1):141-3.
2006: Stephan Michels; Ursula Schmidt-Erfurth; Philip J Rosenfeld
Promising new treatments for neovascular age-related macular degeneration.
Expert opinion on investigational drugs 2006;15(7):779-93.
2006: Ryan M Rich; Philip J Rosenfeld; Carmen A Puliafito; Sander Dubovy; Janet L Davis; Harry W Flynn; Serafin Gonzalez; William J Feuer; Richard C Lin; Geeta Lalchandani-Lalwani; Jackie K Nguyen; Gaurav Kumar
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Retina (Philadelphia, Pa.) 2006;26(5):495-511.
2006: Robert Wirthlin; Alice Song; Julia Song; Philip J Rosenfeld
Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.
Archives of ophthalmology 2006;124(5):741-3.
2006: Philip J Rosenfeld; Jeffrey S Heier; Gary Hantsbarger; Naveed Shams
Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Ophthalmology 2006;113(4):623.e1.
2006: Jeffrey S Heier; Andrew N Antoszyk; Peter Reed Pavan; Steven R Leff; Philip J Rosenfeld; Thomas A Ciulla; Richard F Dreyer; Ronald C Gentile; Judy P Sy; Gary Hantsbarger; Naveed Shams
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Ophthalmology 2006;113(4):633.e1-4.
2005: Lawrence J Singerman; Alexander J Brucker; Lee M Jampol; Jennifer I Lim; Philip J Rosenfeld; Andrew P Schachat; Richard F Spaide
Neovascular age-related macular degeneration: roundtable.
Retina (Philadelphia, Pa.) 2005;25(7 Suppl):S1-S22.
2005: Neil M Bressler; Susan B Bressler; Laurie A Haynes; Yong Hao; Peter K Kaiser; Joan W Miller; Joel Naor; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Ursula Schmidt-Erfurth; Jason S Slakter; Andrew Strong; Stéphane Vannier
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Archives of ophthalmology 2005;123(9):1283-5.
2005: Philip J Rosenfeld; Anne E Fung; Carmen A Puliafito
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2005;36(4):336-9.
2005: Philip J Rosenfeld; Andrew A Moshfeghi; Carmen A Puliafito
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2005;36(4):331-5.
2005: Stephan Michels; Philip J Rosenfeld
[Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis].
Klinische Monatsblätter für Augenheilkunde 2005;222(6):480-4.
2005: Stephan Michels; Philip J Rosenfeld; Carmen A Puliafito; Erin Marcus; Anna Venkatraman
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.
Ophthalmology 2005;112(6):1035-47.
2005: Philip J Rosenfeld; Steven D Schwartz; Mark S Blumenkranz; Joan W Miller; Julia A Haller; James D Reimann; William L Greene; Naveed Shams
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
Ophthalmology 2005;112(6):1048-53.
2005: Mohammad Azab; David S Boyer; Neil M Bressler; Susan B Bressler; Ilona Cihelkova; Young Hao; Ilkka Immonen; Jennifer I Lim; Ugo Menchini; Joel Naor; Michael J Potter; Al Reaves; Philip J Rosenfeld; Jason S Slakter; Pavel Soucek; H Andrew Strong; Andrea Wenkstern; Xiang Yao Su; Yit C Yang
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Archives of ophthalmology 2005;123(4):448-57.
2004: Francesco Bandello; Kevin J Blinder; Neil M Bressler; Alison L Brown; Joan W Miller; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Jason S Slakter; Gisele SOUBRANE; H Andrew Strong; Michael Stur
Verteporfin in Photodynamic Therapy: report no. 5.
Ophthalmology 2004;111(11):2144.
2004: Megan A Hunter; Mark T Dunbar; Philip J Rosenfeld
Retinal angiomatous proliferation: clinical characteristics and treatment options.
Optometry (St. Louis, Mo.) 2004;75(9):577-88.
2004: Philip J Rosenfeld; David A Saperstein; Neil M Bressler; Troy A Reaves; Michel Sickenberg; Robert H Rosa; Paul Sternberg; Thomas M Aaberg; Thomas M Aaberg
Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Ophthalmology 2004;111(9):1725-33.
2004: Daniel E Weeks; Yvette P Conley; Hui-Ju Tsai; Tammy S Mah; Silke Schmidt; Eric A Postel; Anita Agarwal; Jonathan L Haines; Margaret Pericak-Vance; Philip J Rosenfeld; T Otis Paul; Andrew W Eller; Lawrence S Morse; JP Dailey; Robert E Ferrell; Michael B Gorin
Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.
American journal of human genetics 2004;75(2):174-89.
2004: Jennifer J Arnold; Kevin J Blinder; Neil M Bressler; Susan B Bressler; Amy Burdan; Laurie Haynes; Jennifer I Lim; Joan W Miller; Michael J Potter; Al Reaves; Philip J Rosenfeld; Michel Sickenberg; Jason S Slakter; Gisele SOUBRANE; H Andrew Strong; Michael Stur
Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials-TAP and VIP report no. 3.
American journal of ophthalmology 2004;137(4):683-96.
2004: Mohammad Azab; Mustapha Benchaboune; Kevin J Blinder; Neil M Bressler; Susan B Bressler; Evangelos S Gragoudas; Gary Edd Fish; Yong Hao; Laurie Haynes; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi Mones; Michael J Potter; Al Reaves; Philip J Rosenfeld; Andrew Strong; Xiang Yao Su; Jason S Slakter; Ursula Schmidt-Erfurth; John A Sorenson
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Retina (Philadelphia, Pa.) 2004;24(1):1-12.
2003: Ingrid U Scott; Harry W Flynn; Philip J Rosenfeld
Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema.
American journal of ophthalmology 2003;136(4):737-9.
2003: Kevin J Blinder; Shannon Bradley; Neil M Bressler; Susan B Bressler; Guy Donati; Yong Hao; Colin Ma; Ugo Menchini; Joan Miller; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; H Andrew Strong; Michael Stur; Xiang Yao Su; Gianni Virgili
Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.
American journal of ophthalmology 2003;136(3):407-18.
2003: Irene Barbazetto; Amy Burdan; Neil M Bressler; Susan B Bressler; Laurie Haynes; Anastasios D Kapetanios; Julius Lukas; Karl Olsen; Michael Potter; Al Reaves; Philip J Rosenfeld; Andrew P Schachat; H Andrew Strong; Andrea Wenkstern
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
Archives of ophthalmology 2003;121(9):1253-68.
2003: Kevin J Blinder; Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donato; Hilel Lewis; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi Mones; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenberg; Lawrence J Singerman; Jason S Slakter; H Andrew Strong; Gianni Virgili; George A Williams
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
Ophthalmology 2003;110(4):667-73.
2002: Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donati; Gary Edd Fish; Laurie A Haynes; Hilel Lewis; Joan W Miller; Jordi M Monés; Michael J Potter; Constantin J Pournaras; Al Reaves; Philip J Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenburg; Lawrence J Singerman; Jason S Slakter; Andrew Strong; Stéphane Vannier
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Archives of ophthalmology 2002;120(10):1307-14.
2002: David A Saperstein; Philip J Rosenfeld; Neil M Bressler; Robert H Rosa; Michel Sickenberg; Paul Sternberg; Thomas M Aaberg; Thomas M Aaberg; Troy A Reaves
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Ophthalmology 2002;109(8):1499-505.
2002: Roy H Loo; Ingrid U Scott; Harry W Flynn; J Donald M Gass; Timothy G Murray; Mary Lou Lewis; Philip J Rosenfeld; William E Smiddy
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.
Retina (Philadelphia, Pa.) 2002;22(1):19-24.
2001: Daniel E Weeks; Yvette P Conley; Hui-Ju Tsai; Tammy S Mah; Philip J Rosenfeld; T Otis Paul; Andrew W Eller; Lawrence S Morse; JP Dailey; Robert E Ferrell; Michael B Gorin
Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions.
American journal of ophthalmology 2001;132(5):682-92.
2001: C E Briggs; D Rucinski; Philip J Rosenfeld; Tatsuo Hirose; Eliot L Berson; Thaddeus P Dryja
Mutations in ABCR (ABCA4) in patients with Stargardt macular degeneration or cone-rod degeneration.
Investigative ophthalmology & visual science 2001;42(10):2229-36.
2001: MT Yen; Philip J Rosenfeld
Persistent indocyanine green angiographic findings in multiple evanescent white dot syndrome.
Ophthalmic surgery and lasers 2001;32(2):156-8.
1999: Homaoun Tabandeh; Philip J Rosenfeld; G Alexandrakis; J P Kronish; Nauman A Chaudhry
Purtscher-like retinopathy associated with pancreatic adenocarcinoma.
American journal of ophthalmology 1999;128(5):650-2.
1999: Homaoun Tabandeh; Harry W Flynn; Ingrid U Scott; Mary Lou Lewis; Philip J Rosenfeld; F Rodriguez; A Rodriguez; Lawrence J Singerman; Joyce C. Schiffman
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization.
Ophthalmology 1999;106(11):2063-7.
1999: G M Caldwell; Laura E Kakuk; IB Griesinger; S A Simpson; Norma J Nowak; Kent W Small; Irene H Maumenee; Philip J Rosenfeld; Paul Sieving; TB Shows; Radha Ayyagari
Bestrophin gene mutations in patients with Best vitelliform macular dystrophy.
Genomics 1999;58(1):98-101.
1998: Nauman A Chaudhry; Homaoun Tabandeh; Philip J Rosenfeld; Darlene Miller; Janet L Davis
Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
Archives of ophthalmology 1998;116(9):1251.
1998: Philip J Rosenfeld; Harry W Flynn; H Richard McDonald; PE Rubsamen; William E Smiddy; J O Sipperley; I Boniuk; A J Packer
Outcomes of vitreoretinal surgery in patients with X-linked retinoschisis.
Ophthalmic surgery and lasers 1998;29(3):190-7.
1995: Philip J Rosenfeld; L B Hahn; Michael A Sandberg; Thaddeus P Dryja; Eliot L Berson
Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
Investigative ophthalmology & visual science 1995;36(11):2186-92.
1994: Philip J Rosenfeld; Victor A McKusick; J S Amberger; T P Dryja
Recent advances in the gene map of inherited eye disorders: primary hereditary diseases of the retina, choroid, and vitreous.
Journal of medical genetics 1994;31(12):903-15.
1992: Philip J Rosenfeld; G S Cowley; T L McGee; Michael A Sandberg; Eliot L Berson; Thaddeus P Dryja
A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
Nature genetics 1992;1(3):209-13.
1987: Thomas J Kelly; Philip J Rosenfeld; R J Wides; E A O'Neill; J J Li; M S Wold
Replication of adenovirus and SV40 chromosomes in vitro.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1987;317(1187):429-38.
1987: K T Jeang; D R Rawlins; Philip J Rosenfeld; J H Shero; Thomas J Kelly; Gary S Hayward
Multiple tandemly repeated binding sites for cellular nuclear factor 1 that surround the major immediate-early promoters of simian and human cytomegalovirus.
Journal of virology 1987;61(5):1559-70.
1987: Philip J Rosenfeld; E A O'Neill; R J Wides; Thomas J Kelly
Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication.
Molecular and cellular biology 1987;7(2):875-86.
1987: K A Jones; J T Kadonaga; Philip J Rosenfeld; Thomas J Kelly; Robert Tjian
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication.
Cell 1987;48(1):79-89.
1986: Philip J Rosenfeld; Thomas J Kelly
Purification of nuclear factor I by DNA recognition site affinity chromatography.
The Journal of biological chemistry 1986;261(3):1398-408.
1985: L Hennighausen; U Siebenlist; D Danner; P Leder; D Rawlins; Philip J Rosenfeld; Thomas J Kelly
High-affinity binding site for a specific nuclear protein in the human IgM gene.
Nature 1985;314(6008):289-92.
1984: D R Rawlins; Philip J Rosenfeld; R J Wides; M D Challberg; Thomas J Kelly
Structure and function of the adenovirus origin of replication.
Cell 1984;37(1):309-19.
1983: M B Donnelly; D S Fleisher; S Y Long; C Y Chen; Philip J Rosenfeld
Simple adding versus differential weighting of MCAT subtest scores.
Journal of medical education 1983;58(7):581-3.
1983: J M Ostrove; Philip J Rosenfeld; J Williams; Thomas J Kelly
In vitro complementation as an assay for purification of adenovirus DNA replication proteins.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(4):935-9.
1981: C W Angus; M D Lane; Philip J Rosenfeld; Thomas J Kelly
Increase in translatable mRNA for mitochondrial pyruvate carboxylase during differentiation of 3T3 preadipocytes.
Biochemical and biophysical research communications 1981;103(4):1216-22.
1973: Hemmi Bhagavan; M Coleman; D B Coursin; Philip J Rosenfeld
Pyridoxal-5-phosphate levels in whole blood in home-reared patients with trisomy 21.
Lancet 1973;1(7808):889-90.